How to buy Abbott Laboratories (ABT) shares in the UK

Learn how to easily invest in Abbott Laboratories shares.

Abbott Laboratories
NYSE: ABT - USD
MEDICAL DEVICES
$126.79
- $0.65 ( - 0.51%)

Abbott Laboratories (ABT) is a leading medical devices business based in the US. It opened the day at $126.78 after a previous close of $127.44. During the day the price has varied from a low of $126.46 to a high of $127.8. The latest price was $126.79 (25 minute delay). Abbott Laboratories is listed on the NYSE and employs 109,000 staff. All prices are listed in US Dollars.

How to buy shares in Abbott Laboratories

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: ABT in this case.
  5. Research Abbott Laboratories shares. The platform should provide the latest information available.
  6. Buy your Abbott Laboratories shares. It's that simple.
The whole process can take as little as 15 minutes.

How has coronavirus impacted Abbott Laboratories's share price?

Since the stock market crash that started in February 2020, Abbott Laboratories's share price has had significant positive movement.

Its last market close was $126.79, which is 31.03% up on its pre-crash value of $87.45 and 105.79% up on the lowest point reached during the March 2020 crash when the shares fell as low as $61.61.

If you had bought $1,000 worth of Abbott Laboratories shares at the start of February 2020, those shares would have been worth $721.80 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,456.82.

Abbott Laboratories share price (NYSE:ABT)

Use our graph to track the performance of ABT stocks over time.

Abbott Laboratories shares at a glance

Information last updated 2021-09-17.
Open$126.78
High$127.8
Low$126.46
Close$126.79
Previous close$127.44
Change$-0.65
Change %-0.51%
Volume8,974,146
Information last updated 2021-09-17.
52-week range$98.8646 - $129.7
50-day moving average$125.048
200-day moving average$119.3781
Wall St. target price$132.05
PE ratio35.7718
Dividend yield$1.71 (1.34%)
Earnings per share (TTM)$3.55
Promoted
eToro Free Stocks

Invest in Abbott Laboratories shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 5x Abbott Laboratories shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Freetrade logo £0 No minimum £2.08
£464.99 total
Capital at risk
eToro Free Stocks logo £0 $50 £2.31
£465.22 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.91
£463.82 total
Capital at risk
Stake logo £0 £50 £2.33
£465.24 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £16.59
£479.50 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £14.95
£477.86 total
Capital at risk
Fineco logo £0 No minimum £4.63
£467.54 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £15.30
£478.21 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Abbott Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Abbott Laboratories price performance over time

Historical closes compared with the last close of $126.79

1 week (2021-09-13) 0.13%
1 month (2021-08-20) 0.37%
3 months (2021-06-18) 14.92%
6 months (2021-03-19) 5.44%
1 year (2020-09-18) 18.65%
2 years (2019-09-19) 52.34%
3 years (2018-09-19) 85.09%
5 years (2016-09-19) 204.20%

Is Abbott Laboratories under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Abbott Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Abbott Laboratories shares trade at around 36x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Abbott Laboratories's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.

PEG ratio

Abbott Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9575. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Abbott Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Abbott Laboratories's PEG ratio in relation to those of similar companies.

EBITDA

Abbott Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $11.7 billion (£8.5 billion).

The EBITDA is a measure of a Abbott Laboratories's overall financial performance and is widely used to measure a its profitability.

To put that into context you can compare it against similar companies.

Financials

Revenue TTM $40.2 billion
Operating margin TTM 20.31%
Gross profit TTM $19.6 billion
Return on assets TTM 7.19%
Return on equity TTM 19.66%
Profit margin 15.85%
Book value $19.066
Market capitalisation $225.1 billion

TTM: trailing 12 months

How to short and sell Abbott Laboratories shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "ABT.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 10.2 million Abbott Laboratories shares held short by investors – that's known as the "short interest". This figure is 14.4% down from 11.9 million last month.

There are a few different ways that this level of interest in shorting Abbott Laboratories shares can be evaluated.

Short interest ratio (SIR)

Abbott Laboratories's "short interest ratio" (SIR) is the quantity of Abbott Laboratories shares currently shorted divided by the average quantity of Abbott Laboratories shares traded daily (recently around 4.0 million). Abbott Laboratories's SIR currently stands at 2.54. In other words for every 100,000 Abbott Laboratories shares traded daily on the market, roughly 2540 shares are currently held short.

To gain some more context, you can compare Abbott Laboratories's short interest ratio against those of similar companies.

However Abbott Laboratories's short interest can also be evaluated against the total number of Abbott Laboratories shares, or, against the total number of tradable Abbott Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Abbott Laboratories's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Abbott Laboratories shares in existence, roughly 10 shares are currently held short) or 0.0058% of the tradable shares (for every 100,000 tradable Abbott Laboratories shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Abbott Laboratories.

Find out more about how you can short Abbott Laboratories stock.

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Abbott Laboratories.

Total ESG risk score

Abbott Laboratories's total ESG risk: 32.35

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Abbott Laboratories's overall score of 32.35 (as at 12/31/2018) is pretty weak – landing it in it in the 61st percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Abbott Laboratories is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

To gain some more context, you can compare Abbott Laboratories's total ESG risk score against those of similar companies.

Environmental score

Abbott Laboratories's environmental score: 3.98/100

Abbott Laboratories's environmental score of 3.98 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Abbott Laboratories is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Social score

Abbott Laboratories's social score: 20.71/100

Abbott Laboratories's social score of 20.71 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Abbott Laboratories is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Governance score

Abbott Laboratories's governance score: 13.15/100

Abbott Laboratories's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Abbott Laboratories is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Controversy score

Abbott Laboratories's controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Abbott Laboratories scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Abbott Laboratories hasn't always managed to keep its nose clean.

Wondering how that compares? Below are the controversy scores of similar companies.

Environmental, social, and governance (ESG) summary

Abbott Laboratories was last rated for ESG on: 2019-01-01.

Total ESG score 32.35
Total ESG percentile 60.66
Environmental score 3.98
Environmental score percentile 5
Social score 20.71
Social score percentile 5
Governance score 13.15
Governance score percentile 5
Level of controversy 3

Abbott Laboratories share dividends

1.3%

Dividend yield: 1.34% of stock value

1.4%

Forward annual dividend yield: 1.41% of stock value

36.6%

Dividend payout ratio: 36.59% of net profits

Abbott Laboratories has recently paid out dividends equivalent to 1.34% of its share value annually.

Abbott Laboratories has paid out, on average, around 36.59% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.41% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 1.41% return on their shares, in the form of dividend payments. In Abbott Laboratories's case, that would currently equate to about $1.71 per share.

While Abbott Laboratories's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.

Abbott Laboratories's most recent dividend payout was on 15 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 October 2021 (the "ex-dividend date").

Abbott Laboratories's dividend yield is perhaps best considered in relation to those of similar companies.

Have Abbott Laboratories's shares ever split?

Abbott Laboratories's shares were split on a 10000:4798 basis on 1 January 2013. So if you had owned 4798 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your Abbott Laboratories shares – just the quantity. However, indirectly, the new 52% lower share price could have impacted the market appetite for Abbott Laboratories shares which in turn could have impacted Abbott Laboratories's share price.

Share price volatility

Over the last 12 months, Abbott Laboratories's shares have ranged in value from as little as $98.8646 up to $129.7. A popular way to gauge a stock's volatility is its "beta".

ABT.US volatility(beta: 0.65)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Abbott Laboratories's is 0.6485. This would suggest that Abbott Laboratories's shares are less volatile than average (for this exchange).

To put Abbott Laboratories's beta into context you can compare it against those of similar companies.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site